Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
Ankara, Turkey
University hospital in Ankara
Yukarı Bahçelievler, Mareşal Fevzi Çakmak Cd. No - 45, 06490 Çankaya/Ankara
About Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
During the past decade, Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-03-08
2022-08-12
Completed
1,301
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
2021-10-07
2026-09-30
Recruiting
550
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü"
#1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "GOG Foundation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
According to Clinical.Site data, the most researched conditions in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü" are
"Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü" in a lesser frequency.
Clinical Trials Intervention Types at Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
Most popular intervention types in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "Abemaciclib" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
The vast majority of trials in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü" are
2 trials for "Female" genders.
Clinical Trials Status at Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü
Currently, there are NaN active trials in "Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Baskent Universitesi Ankara Hastanesi; Tıbbi Onkoloji Bölümü, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".